{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T11:39:23Z","timestamp":1790163563476,"version":"4.1.0"},"reference-count":60,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2019,1,4]],"date-time":"2019-01-04T00:00:00Z","timestamp":1546560000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010621","name":"Uniwersytet Medyczny w Lublinie","doi-asserted-by":"publisher","award":["332"],"award-info":[{"award-number":["332"]}],"id":[{"id":"10.13039\/501100010621","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Gestational diabetes mellitus (GDM) is considered to be one of the most frequent medical complication observed among pregnant women. The role of adipokines in the pathogenesis of GDM remains strictly unknown. Different adipokines have been studied throughout gestation, and they have been proposed as biomarkers of GDM and other pregnancy-related complications; however, there is no biomarker reported for GDM screening at present. The aim of this study was to evaluate serum nesfatin-1 and vaspin levels in GDM and non-GDM women, to characterize the correlation between these adipokines, and to assess the potential role of circulating adipokines in the prediction of risk of gestational diabetes mellitus. Serum concentrations of nesfatin-1 and vaspin were measured in 153 women with GDM, and in 84 patients with uncomplicated pregnancy by enzyme-linked immunosorbent assay (ELISA) kits, according to the manufacturer\u2019s instructions. Circulating levels of nesfatin-1 and vaspin were significantly lower in the GDM group than in the control group. Nesfatin-1 levels were negatively correlated with vaspin levels. The results of this study point out the possible role of nesfatin-1 and vaspin as potential novel biomarkers for the prediction and early diagnosis of GDM. Further studies are necessary to evaluate the influence of nesfatin-1 and vaspin on glucose metabolism in the early stages of GDM.<\/jats:p>","DOI":"10.3390\/ijms20010159","type":"journal-article","created":{"date-parts":[[2019,1,4]],"date-time":"2019-01-04T11:34:26Z","timestamp":1546601666000},"page":"159","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["Nesfatin-1 and Vaspin as Potential Novel Biomarkers for the Prediction and Early Diagnosis of Gestational Diabetes Mellitus"],"prefix":"10.3390","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2224-6365","authenticated-orcid":false,"given":"Radzis\u0142aw","family":"Mierzy\u0144ski","sequence":"first","affiliation":[{"name":"Chair and Department of Obstetrics and Perinatology, Medical University of Lublin, Poland, ul. Jaczewskiego 8, 20-954 Lublin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"El\u017cbieta","family":"Poniedzia\u0142ek-Czajkowska","sequence":"additional","affiliation":[{"name":"Chair and Department of Obstetrics and Perinatology, Medical University of Lublin, Poland, ul. Jaczewskiego 8, 20-954 Lublin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominik","family":"D\u0142uski","sequence":"additional","affiliation":[{"name":"Chair and Department of Obstetrics and Perinatology, Medical University of Lublin, Poland, ul. Jaczewskiego 8, 20-954 Lublin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4118-7698","authenticated-orcid":false,"given":"Jolanta","family":"Patro-Ma\u0142ysza","sequence":"additional","affiliation":[{"name":"Chair and Department of Obstetrics and Perinatology, Medical University of Lublin, Poland, ul. Jaczewskiego 8, 20-954 Lublin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7295-0409","authenticated-orcid":false,"given":"\u017baneta","family":"Kimber-Trojnar","sequence":"additional","affiliation":[{"name":"Chair and Department of Obstetrics and Perinatology, Medical University of Lublin, Poland, ul. Jaczewskiego 8, 20-954 Lublin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4516-5995","authenticated-orcid":false,"given":"Maciej","family":"Majsterek","sequence":"additional","affiliation":[{"name":"Chair and Department of Obstetrics and Perinatology, Medical University of Lublin, Poland, ul. Jaczewskiego 8, 20-954 Lublin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo\u017cena","family":"Leszczy\u0144ska-Gorzelak","sequence":"additional","affiliation":[{"name":"Chair and Department of Obstetrics and Perinatology, Medical University of Lublin, Poland, ul. Jaczewskiego 8, 20-954 Lublin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2019,1,4]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"American Diabetes Association (2003). Gestational diabetes mellitus. Diabetes Care, 26, 103\u2013105.","DOI":"10.2337\/diacare.26.2007.S103"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"31","DOI":"10.2471\/BLT.08.062554","article-title":"The worldwide incidence of preterm birth: A systematic review of maternal mortality and morbidity","volume":"88","author":"Beck","year":"2010","journal-title":"Bull. World Health Organ."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/S2213-8587(13)70176-1","article-title":"Adipokines in gestational diabetes","volume":"2","author":"Fasshauer","year":"2014","journal-title":"Lancet Diabetes Endocrinol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"R77","DOI":"10.1530\/JOE-16-0211","article-title":"Adipose tissue in control of metabolism","volume":"231","author":"Luo","year":"2016","journal-title":"J. Endocrinol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/nrendo.2012.96","article-title":"Gestational Diabetes Mellitus: Risks and Management during and after Pregnancy","volume":"8","author":"Buchanan","year":"2012","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1365-2265.2011.04234.x","article-title":"Leptin, adiponectin and other adipokines in gestational diabetes mellitus and pre-eclampsia","volume":"76","author":"Miehle","year":"2012","journal-title":"Clin. Endocrinol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.npep.2011.12.002","article-title":"Nesfatin-1, a unique regulatory neuropeptide of the brain","volume":"46","author":"Krzystanek","year":"2012","journal-title":"Neuropetides"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"6986","DOI":"10.2174\/138161281939131127143422","article-title":"Role of NUCB2\/nesfatin-1 as a possible biomarker","volume":"19","author":"Aydin","year":"2013","journal-title":"Curr. Pharm. Des."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.neuroscience.2008.07.054","article-title":"Distribution and neuropeptide coexistence of nucleobindin-2 mRNA\/nesfatin-like immunoreactivity in the rat CNS","volume":"156","author":"Foo","year":"2008","journal-title":"Neuroscience"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"R45","DOI":"10.1530\/JOE-16-0361","article-title":"Nesfatin-1: Functions and physiology of a novel regulatory peptide","volume":"232","author":"Dore","year":"2017","journal-title":"J. Endocrinol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.regpep.2009.11.003","article-title":"Fasting plasma levels of nesfatin-1 in patients with Type 1 and Type 2 diabetes mellitus and the nutrient-related fluctuation of nesfatin-1 level in normal humans","volume":"159","author":"Li","year":"2010","journal-title":"Regul. Pept."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"4751","DOI":"10.1021\/cr010170+","article-title":"Serpin structure, mechanism, and function","volume":"102","author":"Gettins","year":"2002","journal-title":"Chem. Rev."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"10610","DOI":"10.1073\/pnas.0504703102","article-title":"Visceral adipose tissue-derived serine protease inhibitor: A unique insulin-sensitizing adipocytokine in obesity","volume":"102","author":"Hida","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/psc.2621","article-title":"Vaspin (serpin A12) in obesity, insulin resistance and inflammation","volume":"20","author":"Heiker","year":"2014","journal-title":"J. Pept. Sci."},{"key":"ref_15","first-page":"579","article-title":"Vaspin and amylin expressed in human and rat placenta and regulated by nutritional status","volume":"24","author":"Caminos","year":"2009","journal-title":"Histol. Histopathol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1007\/s00125-011-2385-0","article-title":"Impact of circulating vaspin levels on metabolic variables in elderly twins","volume":"55","author":"Hida","year":"2012","journal-title":"Diabetologia"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"E1202","DOI":"10.1210\/jc.2011-3297","article-title":"Serum vaspin concentrations are closely related to insulin resistance, and rs770609950 at SERPINA12 genetically defines distinct group with higher serum levels in Japanese population","volume":"97","author":"Teshigawara","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1038\/ijo.2012.133","article-title":"Genetic variation in the vaspin gene affects circulating serum vaspin concentrations","volume":"37","author":"Breitfeld","year":"2013","journal-title":"Int. J. Obes. (Lond.)"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1055\/s-2008-1081499","article-title":"Vaspin (SERPINA12) genotypes and risk of type 2 diabetes: Results from the MONICA\/KORA studies","volume":"118","author":"Kempf","year":"2010","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.bbrc.2011.08.083","article-title":"Vaspin protects vascular endothelial cells against free fatty acid-induced apoptosis through a phosphatidylinositol 3-kinase\/Akt pathway","volume":"413","author":"Jung","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Jung, C.H., Lee, W.J., Hwang, J.Y., Lee, M.J., Seol, S.M., Kim, Y.M., Lee, Y.L., Kim, H.S., Kim, M.-S., and Park, J.-Y. (2012). Vaspin increases nitric oxide bioavailability through the reduction of asymmetric dimethylarginine in vascular endothelial cells. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0052346"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.bbrc.2005.11.039","article-title":"Vaspin gene expression in human adipose tissue: Association with obesity and type 2 diabetes","volume":"339","author":"Kloting","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1007\/s00125-011-2137-1","article-title":"Central vaspin administration acutely reduces food intake and has sustained blood glucose-lowering effects","volume":"54","author":"Kloting","year":"2011","journal-title":"Diabetologia"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1007\/s12020-011-9577-8","article-title":"Cord blood nesfatin-1 and apelin-36 levels in gestational diabetes mellitus","volume":"41","author":"Aslan","year":"2012","journal-title":"Endocrine"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1590\/2359-3997000000288","article-title":"Serum nesfatin-1 levels are decreased in pregnant women newly diagnosed with gestational diabetes","volume":"61","author":"Ademoglu","year":"2017","journal-title":"Arch. Endocrinol. Metab."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1080\/09513590.2016.1180679","article-title":"Low level of Nesfatin-1 is associated with gestational diabetes mellitus","volume":"32","author":"Kucukler","year":"2016","journal-title":"Gynecol. Endocrinol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1080\/09513590.2017.1306849","article-title":"Serum levels of nesfatin-1 are increased in gestational diabetes mellitus","volume":"33","author":"Zhang","year":"2017","journal-title":"Gynecol. Endocrinol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"979","DOI":"10.33549\/physiolres.933186","article-title":"Serum nesfatin-1 levels in patients with different glucose tolerance levels","volume":"65","author":"Algul","year":"2016","journal-title":"Physiol. Res."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1055\/s-0031-1286339","article-title":"Increased plasma levels of nesfatin-1 in patients with newly diagnosed type 2 diabetes mellitus","volume":"120","author":"Zhang","year":"2012","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"7687098","DOI":"10.1155\/2017\/7687098","article-title":"Circulating Nesfatin-1 Levels and Type 2 Diabetes: A Systematic Review and Meta-Analysis","volume":"2017","author":"Zhai","year":"2017","journal-title":"J. Diabetes Res."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"3169","DOI":"10.1210\/en.2009-1358","article-title":"Identification of nesfatin-1 in human and murine adipose tissue: A novel depot-specific adipokine with increased levels in obesity","volume":"151","author":"Ramanjaneya","year":"2010","journal-title":"Endocrinology"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.bbrc.2009.12.014","article-title":"The novel function of nesfatin-1: Antihyperglycemia","volume":"391","author":"Su","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1677\/JOE-09-0254","article-title":"Nucleobindin-2\/nesfatin in the endocrine pancreas: Distribution and relationship to glycaemic state","volume":"204","author":"Foo","year":"2010","journal-title":"J. Endocrinol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1507\/endocrj.K11E-056","article-title":"Nesfatin-1 enhances glucose-induced insulin secretion by promoting Ca2+ influx through L-type channels in mouse islet beta-cells","volume":"58","author":"Nakata","year":"2011","journal-title":"Endocr. J."},{"key":"ref_35","first-page":"R9","article-title":"Nesfatin-1 exerts a direct, glucose-dependent insulinotropic action on mouse islet beta- and MIN6 cells","volume":"208","author":"Gonzalez","year":"2011","journal-title":"J. Endocrinol."},{"key":"ref_36","first-page":"4","article-title":"Nesfatin-1 and its effects on different systems","volume":"19","author":"Ayada","year":"2015","journal-title":"Hippokratia"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.2337\/db11-1755","article-title":"Nesfatin-1 action in the brain increases insulin sensitivity through Akt\/AMPK\/TORC2 pathway in diet-induced insulin resistance","volume":"61","author":"Yang","year":"2012","journal-title":"Diabetes"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1530\/EJE-08-0723","article-title":"Serum Vaspin levels in type 2 diabetic women in relation to microvascular complications","volume":"160","author":"Gulcenik","year":"2009","journal-title":"Eur. J. Endocrinol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1007\/s12020-011-9572-0","article-title":"Vaspin in obesity and diabetes: Pathophysiological and clinical significance","volume":"41","year":"2012","journal-title":"Endocrine"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.diabres.2013.12.002","article-title":"Vaspin inhibited proinflammatory cytokine induced activation of nuclear factor-kappa B and its downstream molecules in human endothelial EA.hy926 cells","volume":"103","author":"Liu","year":"2014","journal-title":"Diabetes Res. Clin. Pract."},{"key":"ref_41","first-page":"30395","article-title":"Vaspin suppresses cytokine-induced inflammation in 3T3-L1 adipocytes via inhibition of NF\u03baB pathway","volume":"17","author":"Zieger","year":"2018","journal-title":"Mol. Cell. Endocrinol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1475-2840-13-41","article-title":"Vaspin inhibits cytokine-induced nuclear factor-kappa B activation and adhesion molecule expression via AMP-activated protein kinase activation in vascular endothelial cells","volume":"13","author":"Jung","year":"2014","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ejphar.2018.07.052","article-title":"Vaspin protects rats against myocardial ischemia\/reperfusion injury (MIRI) through the TLR\/NF-\u03baB signaling pathway","volume":"835","author":"Yuan","year":"2018","journal-title":"Eur. J. Pharmacol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"372","DOI":"10.2337\/db07-1045","article-title":"Serum vaspin concentrations in human obesity and type 2 diabetes","volume":"57","author":"Youn","year":"2008","journal-title":"Diabetes"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.cyto.2012.09.006","article-title":"Serum vaspin levels in women with and without gestational diabetes mellitus during pregnancy and postpartum","volume":"61","author":"Gkiomisi","year":"2013","journal-title":"Cytokine"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1530\/EJE-10-1020","article-title":"Serum vaspin levels in normal pregnancy in comparison with non-pregnant women","volume":"164","author":"Giomisi","year":"2011","journal-title":"Eur. J. Endocrinol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1590\/1414-431x20143432","article-title":"Plasma levels and placental expression of vaspin in pregnant women with diabetes mellitus","volume":"48","author":"Huo","year":"2015","journal-title":"Braz. J. Med. Biol. Res."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s12020-014-0318-7","article-title":"Comparative analysis of vaspin in pregnant women with and without gestational diabetes mellitus and healthy non-pregnant women","volume":"48","author":"Jia","year":"2015","journal-title":"Endocrine"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ejogrb.2014.09.008","article-title":"Serum vaspin levels and vaspin mRNA expression in subcutaneous adipose tissue in women with gestational diabetes mellitus","volume":"182","author":"Mm","year":"2014","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.metabol.2009.11.001","article-title":"Preliminary report: Circulating levels of the adipokine vaspin in gestational diabetes mellitus and preeclampsia","volume":"59","author":"Stepan","year":"2010","journal-title":"Metabolism"},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Yang, W., Li, Y., Tian, T., Wang, L., Lee, P., and Hua, Q. (2017). Serum vaspin concentration in elderly patients with type 2 diabetes mellitus and macrovascular complications. BMC Endocr. Disord., 17.","DOI":"10.1186\/s12902-017-0216-0"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"E506","DOI":"10.1152\/ajpendo.00586.2009","article-title":"Insulin-sensitive obesity","volume":"299","author":"Kloting","year":"2010","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1161\/CIRCRESAHA.111.300049","article-title":"Visceral adipose tissue-derived serine proteinase inhibitor inhibits apoptosis of endothelial cells as a ligand for the cell-surface GRP78\/voltage-dependent anion channel complex","volume":"112","author":"Nakatsuka","year":"2013","journal-title":"Circ. Res."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.diabres.2009.03.008","article-title":"Vaspin and its correlation with insulin sensitivity indices in obese children","volume":"84","author":"Suleymanoglu","year":"2009","journal-title":"Diabetes Res. Clin. Pract."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1210\/jc.2007-1853","article-title":"Serum levels of the adipokine vaspin in relation to metabolic and renal parameters","volume":"93","author":"Seeger","year":"2008","journal-title":"Clin. Endocrinol. Metab."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.diabres.2011.10.004","article-title":"Serum visfatin and vaspin levels in normoglycemic first-degree relatives of Iranian patients with type 2 diabetes mellitus","volume":"95","author":"Akbarzadeh","year":"2012","journal-title":"Diabetes Res. Clin. Pract."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1159\/000321637","article-title":"Serum vaspin concentrations are decreased after exercise-induced oxidative stress","volume":"3","author":"Oberbach","year":"2010","journal-title":"Obes. Facts"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/j.metabol.2011.01.013","article-title":"Lifestyle modification increases circulating concentrations but does not change vaspin concentrations","volume":"60","author":"Kim","year":"2011","journal-title":"Metabolism"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1684\/ecn.2011.0295","article-title":"Short-term effect of weight loss through restrictive bariatric surgery on serum levels of vaspin in morbidly obese subjects","volume":"22","author":"Golpaie","year":"2011","journal-title":"Eur. Cytokine Netw."},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"World Health Organization (2014). Diagnostic criteria and classification of hyperglycaemia first detected in pregnancy. Diabetes Res. Clin. Pract., 103, 341\u2013363.","DOI":"10.1016\/j.diabres.2013.10.012"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/20\/1\/159\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T12:23:28Z","timestamp":1760185408000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/20\/1\/159"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,4]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,1]]}},"alternative-id":["ijms20010159"],"URL":"https:\/\/doi.org\/10.3390\/ijms20010159","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,4]]}}}